Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Pharm Res ; 17(11): 1374-83, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11205730

ABSTRACT

PURPOSE: To investigate the effect of atomization conditions on particle size and stability of spray-freeze dried protein. METHODS: Atomization variables were explored for excipient-free (no zinc added) and zinc-complexed bovine serum albumin (BSA). Particle size was measured by laser diffraction light scattering following sonication in organic solvent containing poly(lactide-co-glycolide) (PLG). Powder surface area was determined from the N2 vapor sorption isotherm. Size-exclusion chromatography (SEC) was used to assess decrease in percent protein monomer. Fourier-transform infrared (FTIR) spectroscopy was employed to estimate protein secondary structure. PLG microspheres were made using a non-aqueous, cryogenic process and release of spray-freeze dried BSA was assessed in vitro. RESULTS: The most significant atomization parameter affecting particle size was the mass flow ratio (mass of atomization N2 relative to that for liquid feed). Particle size was inversely related to specific surface area and the amount of protein aggregates formed. Zinc-complexation reduced the specific surface area and stabilized the protein against aggregation. FTIR data indicated perturbations in secondary structure upon spray-freeze drying for both excipient-free and zinc-complexed protein. CONCLUSIONS: Upon sonication, spray-freeze dried protein powders exhibited friability, or susceptibility towards disintegration. For excipient-free protein, conditions where the mass flow ratio was > -0.3 yielded sub-micron powders with relatively large specific surface areas. Reduced particle size was also linked to a decrease in the percentage of protein monomer upon drying. This effect was ameliorated by zinc-complexation, via a mechanism involving reduction in specific surface area of the powder rather than stabilization of secondary structure. Reduction of protein particle size was beneficial in reducing the initial release (burst) of the protein encapsulated in PLG microspheres.


Subject(s)
Proteins/chemistry , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , Chemistry, Pharmaceutical , Drug Carriers , Drug Stability , Freeze Drying/methods , Lactic Acid/administration & dosage , Lactic Acid/chemistry , Microscopy, Electron, Scanning , Microspheres , Particle Size , Polyglycolic Acid/administration & dosage , Polyglycolic Acid/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer , Polymers/administration & dosage , Polymers/chemistry , Protein Structure, Secondary , Proteins/administration & dosage , Serum Albumin, Bovine/administration & dosage , Serum Albumin, Bovine/chemistry
2.
Biomaterials ; 20(11): 1057-62, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10378806

ABSTRACT

The purpose of this work was to study the degradation of poly(lactide-co-glycolide) (PLG) microspheres in vivo and in vitro. Degradation rate constants were determined by measuring the polymer molecular weight as a function of time by gel-permeation chromatography. The effects of PLG chemistry and the effects of encapsulating the sparingly soluble salt zinc carbonate and the protein recombinant human growth hormone (rhGH) on the degradation rate were assessed. It was found that in vivo degradation was faster than in vitro degradation. In addition, different types of PLGs were found to degrade at different rates depending on the chemistry of the polymer end group and, to a lesser extent, the molecular weight. Finally, zinc carbonate was found to retard the degradation of some PLGs. These degradation studies have proved valuable in the design of sustained release microsphere products.


Subject(s)
Biocompatible Materials , Lactic Acid , Polyglycolic Acid , Polymers , Animals , Biocompatible Materials/chemistry , Biocompatible Materials/metabolism , Biodegradation, Environmental/drug effects , Carbonates/pharmacology , Drug Carriers , Humans , In Vitro Techniques , Lactic Acid/chemistry , Lactic Acid/metabolism , Male , Materials Testing , Microspheres , Molecular Weight , Polyglycolic Acid/chemistry , Polyglycolic Acid/metabolism , Polylactic Acid-Polyglycolic Acid Copolymer , Polymers/chemistry , Polymers/metabolism , Rats , Rats, Sprague-Dawley , Zinc Compounds/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL